Table 1 Clinicopathologic features of the 749 patients with nasopharyngeal carcinoma (NPC)
Feature | No. of patients [cases (%)] |
|---|---|
Sex | |
 Male | 580 (77.4) |
 Female | 169 (22.6) |
WHO pathology | |
 Type I | 5 (0.7) |
 Type II/III | 744 (99.3) |
Clinical stagea | |
 I–II | 257 (34.3) |
 III–IV | 492 (65.7) |
T stagea | |
 T1 | 177 (23.6) |
 T2 | 140 (18.7) |
 T3 | 264 (35.2) |
 T4 | 168 (22.4) |
N stagea | |
 N0 | 184 (24.6) |
 N1 | 409 (54.6) |
 N2 | 106 (14.2) |
 N3 | 50 (6.7) |
Chemotherapy | |
 No chemotherapy | 214 (28.6) |
 Concurrent | 243(32.5) |
 Induction + concurrent | 246 (32.8) |
 Concurrent + adjuvant | 46 (6.1) |